Verified Nov 2026
Other
·

Meyrin, Geneva
·
Since 1937
OM Pharma is a Swiss biopharmaceutical company founded in 1937 and headquartered in Meyrin, Geneva, with 500–1,000 employees and estimated revenue of $100–250 million. The company develops and manufactures therapies for respiratory and urinary tract infections, vascular diseases, and immunological disorders using bacterial lysate technology. It distributes products across more than 100 countries and recently expanded Broncho-Vaxom® availability in China through a partnership.
OM Pharma at a glance
Revenue
$100-250M
Est. band
Employees
500-1,000
Founded
1937
Headquarters
Meyrin, Geneva
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
OM Pharma is a Swiss biopharmaceutical company founded in 1937 and headquartered in Meyrin, Geneva, with 500–1,000 employees and estimated revenue of $100–250 million. The company develops and manufactures therapies for respiratory and urinary tract infections, vascular diseases, and immunological disorders using bacterial lysate technology. It distributes products across more than 100 countries and recently expanded Broncho-Vaxom® availability in China through a partnership.
At a glance
Attribute | Detail |
|---|---|
Founded | 1937 |
Headquarters | Meyrin, Geneva |
Employees | 500-1,000 |
Revenue | $100-250M (estimated) |
What OM Pharma makes
OM Pharma produces prescription and over-the-counter bacterial lysate-based therapies, including Broncho-Vaxom® for respiratory infections and Uro Vaxom® for urinary tract infections, alongside established pharmaceuticals for vascular conditions.
Products and capabilities described on the company's own site include LED, Plastic (source: ompharma.com).
Latest developments
2026-05-22 — We are pleased to announce the appointment of Guillaume CRESSON as Chief Financial Officer. | OM Pharma (linkedin.com)
2026-05-21 — Lotus Pharmaceutical Announces Acquisition of a Specialty Pharmaceutical Product in South Korea, Expanding Portfolio in Urology and Infectious Disease Prevention (lotuspharm.com)
2026-05-04 — Our 2025 Annual Report reflects a growing momentum around a clear conviction: prevention must play a central role in the future of healthcare. | OM Pharma (linkedin.com)
2026-04-19 — OM Pharma and SPH Keyuan Trade advance Broncho-Vaxom® (OM-85) availability across China | OM Pharma (ompharma.com)
2026-01-07 — OM Pharma: Building a Data Foundation for Rapid Growth | Veeva (veeva.com)
2025-09-25 — ALCEDIAG, OM Pharma Suisse and Unilabs Announce Swiss Launch of EDIT-B®, the World’s First Blood Test to Help Differentiate Depression and Bipolar Disorder | ALCEDIAG (alcediag-alcen.com)
Facilities
OM Pharma is headquartered in Meyrin, Geneva. Public sources also reference these locations:
Taiwan — lotuspharm.com
Geneva, Switzerland — lotuspharm.com
Company details
The company operates a modern biotech campus in Meyrin and maintains manufacturing facilities in multiple locations to serve its global distribution network across infectious disease prevention and vascular treatment markets. OM Pharma was founded in 1937, has an estimated 500-1,000 employees, and is headquartered in Meyrin, Geneva.
Frequently asked questions
What does OM Pharma do?
OM Pharma is a Swiss biopharmaceutical company founded in 1937 and headquartered in Meyrin, Geneva, with 500–1,000 employees and estimated revenue of $100–250 million. The company develops and manufactures therapies for respiratory and urinary tract infections, vascular diseases, and immunological disorders using bacterial lysate technology. It distributes products across more than 100 countries and recently expanded Broncho-Vaxom® availability in China through a partnership.
Where is OM Pharma headquartered?
OM Pharma is headquartered in Meyrin, Geneva (1 Place des Cinq-Continents, Meyrin, Geneva, 1217).
When was OM Pharma founded?
OM Pharma was founded in 1937.
How big is OM Pharma?
OM Pharma has an estimated 500-1,000 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
